fecal lactoferrin
Selected indexed studies
- C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis. (Am J Gastroenterol, 2015) [PMID:25964225]
- Fecal Lactoferrin and Other Putative Fecal Biomarkers in Crohn's Disease: Do They Still Have a Potential Clinical Role? (Digestion, 2021) [PMID:34518458]
- Fecal Lactoferrin Testing. (Gastroenterol Hepatol (N Y), 2018) [PMID:30804718]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis. (2015) pubmed
- Fecal Lactoferrin and Other Putative Fecal Biomarkers in Crohn's Disease: Do They Still Have a Potential Clinical Role? (2021) pubmed
- Fecal Lactoferrin Testing. (2018) pubmed
- Fecal Lactoferrin for Assessment of Inflammatory Bowel Disease Activity: A Systematic Review and Meta-Analysis. (2020) pubmed
- Fecal markers: calprotectin and lactoferrin. (2012) pubmed
- Fecal lactoferrin as a noninvasive biomarker in inflammatory bowel diseases. (2012) pubmed
- Trajectory of fecal lactoferrin for predicting prognosis in ulcerative colitis. (2023) pubmed
- Fecal lactoferrin in discriminating inflammatory bowel disease from irritable bowel syndrome: a diagnostic meta-analysis. (2014) pubmed
- Relevance of fecal calprotectin and lactoferrin in the post-operative management of inflammatory bowel diseases. (2016) pubmed
- AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Ulcerative Colitis. (2023) pubmed